Heartland Advisors Inc. Increases Position in Accuray Incorporated (NASDAQ:ARAY)

Heartland Advisors Inc. increased its position in shares of Accuray Incorporated (NASDAQ:ARAY - Free Report) by 14.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,824,750 shares of the medical equipment provider's stock after purchasing an additional 472,800 shares during the period. Heartland Advisors Inc. owned approximately 3.72% of Accuray worth $7,573,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Prudential Financial Inc. bought a new stake in Accuray in the fourth quarter worth about $43,000. Intech Investment Management LLC bought a new stake in shares of Accuray during the 3rd quarter worth approximately $41,000. Thrivent Financial for Lutherans bought a new stake in shares of Accuray during the 3rd quarter worth approximately $57,000. SG Americas Securities LLC boosted its holdings in Accuray by 37.4% during the 4th quarter. SG Americas Securities LLC now owns 45,079 shares of the medical equipment provider's stock valued at $89,000 after acquiring an additional 12,259 shares during the period. Finally, Perkins Capital Management Inc. grew its position in Accuray by 18.3% in the 4th quarter. Perkins Capital Management Inc. now owns 68,000 shares of the medical equipment provider's stock valued at $135,000 after acquiring an additional 10,500 shares during the last quarter. 64.08% of the stock is owned by hedge funds and other institutional investors.

Accuray Trading Up 3.1 %

Accuray stock traded up $0.06 during trading hours on Wednesday, hitting $1.84. The company had a trading volume of 403,169 shares, compared to its average volume of 715,095. The company has a debt-to-equity ratio of 3.51, a quick ratio of 0.88 and a current ratio of 1.62. The firm has a market cap of $188.69 million, a P/E ratio of -36.70 and a beta of 1.46. The company has a 50-day moving average price of $2.08 and a two-hundred day moving average price of $1.98. Accuray Incorporated has a 1 year low of $1.40 and a 1 year high of $2.95.

Remove Ads

Accuray (NASDAQ:ARAY - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.03. Accuray had a negative net margin of 0.96% and a negative return on equity of 9.75%. On average, sell-side analysts anticipate that Accuray Incorporated will post 0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded Accuray from a "buy" rating to a "hold" rating in a research report on Saturday.

Accuray Company Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.